Hospital Universitario Central de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (31)

2023

  1. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

    Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539

2021

  1. Btla/hvem axis induces nk cell immunosuppression and poor outcome in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 8

  2. Lag‐3 blockade with relatlimab (Bms‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 9

2020

  1. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

    Bone Marrow Transplantation

  2. Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer

    International Journal of Molecular Sciences, Vol. 21, Núm. 10

2019

  1. NK cell-based immunotherapy in cancer metastasis

    Cancers, Vol. 11, Núm. 1

  2. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling

    Frontiers in Immunology, Vol. 10

2018

  1. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

    Frontiers in immunology, Vol. 9, pp. 2917

2017

  1. Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

    OncoImmunology, Vol. 6, Núm. 10

  2. Immune and inflammatory responses to DNA damage in cancer and aging

    Mechanisms of Ageing and Development, Vol. 165, pp. 10-16

  3. Immunosurveillance of Malignant Cells with Complex Karyotypes

    Trends in Cell Biology

  4. Involvement of autophagy in NK cell development and function

    Autophagy

  5. NKG2D Signaling: The Immune Subversive Side of HDAC3

    Trends in Immunology

2016

  1. Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

    OncoImmunology, Vol. 5, Núm. 2

  2. The Molecular Basis of the Immune Response to Stressed Cells and Tissues

    The Innate Immune Response to Non-infectious Stressors: Human and Animal Models (Elsevier Inc.), pp. 53-79

2015

  1. Pleiotropic anti-angiogenic and anti-oncogenic activities of the novel mithralog demycarosyl-3D-ß-D-digitoxosyl-mithramycin SK (EC-8042)

    PLoS ONE, Vol. 10, Núm. 11

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

  2. Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

    BioMed Research International, Vol. 2014

  3. Molecular bases for the regulation of NKG2D ligands in cancer

    Frontiers in Immunology

2013

  1. Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor

    Journal of Immunology, Vol. 190, Núm. 8, pp. 4408-4419